Literature DB >> 7630483

Cellular defence mechanisms in the striatum of young and aged rats subchronically exposed to manganese.

M S Desole1, G Esposito, R Migheli, L Fresu, S Sircana, D Zangani, M Miele, E Miele.   

Abstract

A deficiency of striatal dopamine (DA) is generally accepted as an expression of manganese (Mn) toxicity in experimental animals. Since compromised cellular defence mechanisms may be involved in Mn neurotoxicity, we investigated the response of the neuronal antioxidant system [ascorbic acid (AA) oxidation, glutathione (GSH) and uric acid levels] and neurochemical changes in the striatum in aged rats exposed to Mn. Levels of dopamine (DA), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), AA, dehydroascorbic acid (DHAA), GSH and uric acid were determined after subchronic oral exposure to MnCl2 200 mg/kg (3-month-old rats) and 30-100-200 mg/kg (20-month-old-rats). Aged rats had basal levels of striatal DA, DOPAC, HVA, 5-HT, 5-HIAA, GSH and AA lower than those of young rats. In the striatum of aged rats, Mn induced biphasic changes in the levels of DA, DOPAC, HVA (an increase at the lower dose and a decrease at the higher dose) and DHAA (opposite changes). Mn decreased GSH levels and increased uric acid levels both in the striatum and in synaptosomes in all groups of aged rats. All of these parameters were affected to a lesser extent in young rats. In conclusion, the response of cellular defence mechanisms in aged rats is consistent with a Mn-induced increase in the formation of reactive oxygen species. An age-related impairment of the neuronal antioxidant system may play an enabling role in Mn neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630483     DOI: 10.1016/0028-3908(94)00140-n

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

1.  Peumus boldus (Boldo) Aqueous Extract Present Better Protective Effect than Boldine Against Manganese-Induced Toxicity in D. melanogaster.

Authors:  Matheus Chimelo Bianchini; Claudia Ortiz Alves Gularte; Dandara Fidélis Escoto; Geovana Pereira; Mateus Cristofari Gayer; Rafael Roehrs; Félix Alexandre Antunes Soares; Robson L Puntel
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

2.  Ceruloplasmin alters the tissue disposition and neurotoxicity of manganese, but not its loading onto transferrin.

Authors:  Thomas Jursa; Donald R Smith
Journal:  Toxicol Sci       Date:  2008-11-12       Impact factor: 4.849

3.  Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT-Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment.

Authors:  Michael D Taylor; Harvey J Clewell; Melvin E Andersen; Jeffry D Schroeter; Miyoung Yoon; Athena M Keene; David C Dorman
Journal:  J Toxicol       Date:  2012-05-07

Review 4.  Methylcyclopentadienyl manganese tricarbonyl: health risk uncertainties and research directions.

Authors:  J M Davis
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

5.  Manganese-induced atypical parkinsonism is associated with altered Basal Ganglia activity and changes in tissue levels of monoamines in the rat.

Authors:  Safa Bouabid; Claire Delaville; Philippe De Deurwaerdère; Nouria Lakhdar-Ghazal; Abdelhamid Benazzouz
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

Review 6.  Parkinson's Disease and the Metal-Microbiome-Gut-Brain Axis: A Systems Toxicology Approach.

Authors:  Lady Johanna Forero-Rodríguez; Jonathan Josephs-Spaulding; Stefano Flor; Andrés Pinzón; Christoph Kaleta
Journal:  Antioxidants (Basel)       Date:  2021-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.